BTIG analyst Ryan Zimmerman maintained a Buy rating on Tactile Systems Technology (NASDAQ:TCMD) on Wednesday, setting a price target of $69, which is approximately 28.68% above the present share price of $53.62.
Zimmerman expects Tactile Systems Technology to post earnings per share (EPS) of -$0.12 for the second quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Strong Buy rating of shares in Tactile Systems Technology, with an average price target of $67.
The analysts price targets range from a high of $70 to a low of $62.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $42.77 million and a net profit of -$4.08 million. The company's market cap is $1.07 billion.
According to TipRanks.com, BTIG analyst Ryan Zimmerman is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 33.3% and a 64.95% success rate.
Tactile Systems Technology, Inc. is a medical technology company. It develops and provides innovative medical devices for the treatment of chronic diseases at home. The company focus on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. It possesses a platform to deliver at-home healthcare solutions throughout the United States. Tactile Systems Technology was founded on January 30, 1995 and is headquartered in Minneapolis, MN.